Last reviewed · How we verify
Ivermectin Cream, 1% — Competitive Intelligence Brief
phase 3
Antiparasitic agent
Glutamate-gated chloride channels (invertebrate-specific)
Dermatology
Small molecule
Live · refreshed every 30 min
Target snapshot
Ivermectin Cream, 1% (Ivermectin Cream, 1%) — Actavis Inc.. Ivermectin binds to glutamate-gated chloride channels in parasites and arthropods, causing paralysis and death of the organisms.
Comparator set (6 drugs)
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Ivermectin Cream, 1% TARGET | Ivermectin Cream, 1% | Actavis Inc. | phase 3 | Antiparasitic agent | Glutamate-gated chloride channels (invertebrate-specific) | |
| ''albendazole'' and ''ivermectin'' | ''albendazole'' and ''ivermectin'' | Centre d'Appui à la lutte contre la Maladie | marketed | Antihelmintic/Antiparasitic agents | β-tubulin (albendazole); glutamate-gated chloride channels (ivermectin) | |
| Ivermectin 1% cream (IVM) | Ivermectin 1% cream (IVM) | Galderma R&D | marketed | Antiparasitic agent | Glutamate-gated chloride channels (invertebrate-specific) | |
| Pyrimethamine (PYR) | Pyrimethamine (PYR) | Erasmus Medical Center | marketed | Antifolate antimalarial and antiparasitic agent | Dihydrofolate reductase (DHFR) | |
| Antimoniate of N-methylglucamine | Antimoniate of N-methylglucamine | University of Brasilia | marketed | Antiparasitic agent | Leishmania glycolytic enzymes and mitochondrial function | |
| Atovaquone Oral Suspension | Atovaquone Oral Suspension | University of Oxford | marketed | Antiparasitic agent | Cytochrome bc1 complex (Complex III) | |
| Ivermectin 1% cream | Ivermectin 1% cream | Insel Gruppe AG, University Hospital Bern | marketed | Antiparasitic agent | Glutamate-gated chloride channels |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Antiparasitic agent class)
- Actavis Inc. · 2 drugs in this class
- Galderma R&D · 1 drug in this class
- Insel Gruppe AG, University Hospital Bern · 1 drug in this class
- Padagis LLC · 1 drug in this class
- U.S. Army Medical Research and Development Command · 1 drug in this class
- University of Brasilia · 1 drug in this class
- University of Oxford · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Ivermectin Cream, 1% CI watch — RSS
- Ivermectin Cream, 1% CI watch — Atom
- Ivermectin Cream, 1% CI watch — JSON
- Ivermectin Cream, 1% alone — RSS
- Whole Antiparasitic agent class — RSS
Cite this brief
Drug Landscape (2026). Ivermectin Cream, 1% — Competitive Intelligence Brief. https://druglandscape.com/ci/ivermectin-cream-1. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing